-
Beta-blockers, taken by millions after a heart attack, found to be ineffective for people with uncomplicated heart attacks (normal heart function thereafter) and presents increased risk of harm to women. Changes to management likely in the works for this population.
Medical Mythbusting Commentary for May 27, 2026 Source:Common heart drug taken by millions found useless — and possibly dangerous Reference:Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial
-
Remnant cholesterol levels found to be an independent risk factor for heart disease. We discuss what this is and what the approach to management entails.
Medical Mythbusting Commentary for May 26, 2026 Source:Experts have found a new type of cholesterol. And it could be the most dangerous Reference: Source: openevidence.comRemnant cholesterol — defined as total cholesterol minus LDL-C minus HDL-C — is an emerging and increasingly recognized causal risk factor for ASCVD. Management centers on lifestyle modification as first-line therapy,…
-
Origami DNA nanocapsules being studied for its ability to deliver medications in narrowed or clogged arteries, releasing clot-busting or plaque-clearing drugs exactly where needed. In vivo studies to hopefully follow.
Medical Mythbusting Commentary for May 12, 2026 Source:Israel is building tiny robots that protect your heart Reference:Engineering a Mechanoresponsive DNA Origami Capsule for Drug Delivery to Narrowed Arteries
-
New way to lower high cholesterol by stopping its production demonstrated in mice. It is also designed for a subset of people with a genetically inherited condition that causes significant elevated levels.
Medical Mythbusting Commentary for April 17, 2026 Source:Scientists Discover Game-Changing New Way To Treat High Cholesterol Reference: A human iPSC-derived hepatocyte screen identifies compounds that inhibit production of Apolipoprotein B
-
Many caveats and confounding factors inherent in this study that claims irregular bedtime doubles cardiovascular disease risk.
Medical Mythbusting Commentary for April 2, 2026 Source:Irregular Bedtime Doubles Cardiac Risk Reference:Sleep timing irregularity in midlife: association with incident major adverse cardiac events and cardiovascular disease mortality over a 10-year follow-up
-
After a heart attack, beta-blockers are often a lifelong medicine. Maybe they shouldn’t be for stable low-risk post-MI patients
Medical Mythbusting Commentary for March 31, 2026 Source:After a heart attack, beta-blockers are often a lifelong medicine. Maybe they shouldn’t be
-
It stands to reason that most medications designed to manage progressive chronic disease once discontinued will see a relapse or progression of said disease process.
Medical Mythbusting Commentary for March 25, 2026 Source:Stopping GLP-1 drugs like Ozempic erodes heart health benefits quickly, new study finds Reference:GLP-1RA discontinuation and risks of major adverse cardiovascular events in adults with type 2 diabetes: A target emulation trial.
-
Several heart health myths like ‘diabetes won’t harm my heart’ or ‘if it runs in my family there is nothing I can do’, debunked.
Medical Mythbusting Commentary for March 2, 2026 Source:Doctor debunks 3 common heart health myths